ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

EKF Ekf Diagnostics Holdings Plc

27.60
-0.20 (-0.72%)
Last Updated: 09:40:20
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Ekf Diagnostics Holdings Plc LSE:EKF London Ordinary Share GB0031509804 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.20 -0.72% 27.60 27.10 28.90 27.60 27.60 27.60 49,884 09:40:20
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Med, Dental, Hosp Eq-whsl 52.61M 2.35M 0.0052 53.46 126.47M
Ekf Diagnostics Holdings Plc is listed in the Med, Dental, Hosp Eq-whsl sector of the London Stock Exchange with ticker EKF. The last closing price for Ekf Diagnostics was 27.80p. Over the last year, Ekf Diagnostics shares have traded in a share price range of 22.50p to 37.50p.

Ekf Diagnostics currently has 454,930,564 shares in issue. The market capitalisation of Ekf Diagnostics is £126.47 million. Ekf Diagnostics has a price to earnings ratio (PE ratio) of 53.46.

Ekf Diagnostics Share Discussion Threads

Showing 3526 to 3550 of 4850 messages
Chat Pages: Latest  146  145  144  143  142  141  140  139  138  137  136  135  Older
DateSubjectAuthorDiscuss
20/5/2021
14:48
This whole thing is a mess!HL have just emailed to say that only professional investors can take part in the Trellus offer.I've corrected them and await a reply.
scorpio51
20/5/2021
14:34
MyHealthChecked Plc

("MyHealthChecked" or the "Company")

Related Party Transaction

Manufacturing Agreement and Purchase order with EKF Diagnostic Holdings plc

MyHealthChecked Plc (AIM: MHC), the consumer home-testing healthcare company, announces that on 20 May 2021 it signed a Manufacturing Agreement and placed a further purchase order of GBP1.425m with EKF Diagnostic Holdings plc ("EKF") for PrimeStore(R) MTM sample collection devices.

adobbing
20/5/2021
14:26
Nothing like price to change sentiment. This board is heaving with excitement. Good for you chaps - you've been in the doldrums for a fair bit. If (and only IF) we make a clean bo > 80 I can join your side for a bit. Until then I leave the conversation to someone else. Ta.
tongosti
20/5/2021
14:17
Long conversation with barclays where I eventually informed them of exactly where to look, they will phone me later with an update on their investigations. In the meantime contacted Walbrook who in turn had referred to the finance director to facilitate options for my application to be considered, with proof of entitlement of course so that the failings of Barclays don’t impact on me. Now that’s how you engender loyalty!
ppmm
20/5/2021
13:52
Re: A J Bell. Be aware that if you use their Secure Message system (as they request) it does not allow symbols, so you cannot use a £ sign!
Cd

cambridgedon
20/5/2021
13:03
AJBell must be watching in,

literally got the message from them now with mistakes on the name Tellus instead of Trellus and not giving an option to ask for more shares except by emailing them.

Good so far....not

mg1982
20/5/2021
12:49
both AJBell and HL have yet to say anything. I have messaged both but still no response.

It will be a last minute mad rush like last time with VRCI

mg1982
20/5/2021
12:03
Yep!
CD

cambridgedon
20/5/2021
11:51
Mine have been showing in my II account for some time under a strange symbol of 9876536, with no value against them.

Presumably these are the ones that are locked up?

adobbing
20/5/2021
11:44
My daughter, who is with II, has just got her IPO details (less the price which is yet to be set!) She also told me that the free shares are already being shown on her account. Why can't the other brokers/platforms do this? (FAO A J Bell.)
CD

cambridgedon
20/5/2021
11:42
Had the same message as sharw on my II account.
Your option appears only to be to “pledge” your cash amount.

With a deadline of today?

Your pledge may be cut back if oversubscribed.

Not sure how they assess that without a share price, presumably if you pledge £1000 they could scale that back, so that you end up paying less?

Then when they assess the demand they decide on the price of the shares and therefore the price of each share.

Here’s hoping it’s £1000 per share, then the ones I’ve already got could be worth a few ££ !

adobbing
20/5/2021
10:51
Walbrook just advuised there will be announcements from them this afternoon. They will state the price of the share, give access to the application form and require completion by Monday lunchtime.
faz
20/5/2021
10:37
From AJBEll yesterday I’ve spoken to our Corporate Actions Team who are aware of the event and monitoring for the documents being released today.

Once the finer details are available, they’ll send a corporate action notice to your online account detailing how to apply for the shares.

faz
20/5/2021
10:27
Congrats sharw, you're evidently with a decent broker! Barclays have confirmed (1) they don't allow clients to participate in new IPOs, and (2) that Broadway are holding Trellus shares on trust for holders for 365 days from admission (from memory), so won't be allocating them around to the various stockbrokers until that time has elapsed.

Rather than phoning up all and sundry to find a way round (1), does anyone know of one? Perhaps Broadway themselves can enable something to happen?

And what implication does (2) above have for holders of Trellus post-IPO who wish to sell their shares if they shoot up (for example), given that they won't be distributed out to holders for a year?

EDIT - apologies, as regards (2) I doubt there's anything anyone can do as:

"All such converted shares will be locked-up for a period of twelve months following Admission but new Trellus Shares acquired through the Restricted Offer will not be subject to lock-up."

rivaldo
20/5/2021
10:01
email from ii this morning telling me to check out notice of corporate action.

On my a/c it says:
Restricted Offer
Subscription price: To be confirmed
New shares: Upon receipt
Tellus Health plc has announced a Restricted Offer, whereby holders may subscribe for additional shares in the company. Your options are:

OPTION 1: Do nothing (Default). You will keep your current holding if you take no action.

OPTION 2: Subscribe for New Shares. You need to specify the total amount of cash you wish to invest. Subscriptions may be subject to scaling back. Please ensure you have cleared funds in your account by our deadline date.

At time of writing the company have not announced the subscription price, nor have they issued an application form,and we have so far been unable to clarify full details of the acceptance procedure with their broker. We have also not been able to confirm for certain if we are eligible to participate or not. Therefore, any elections will be done on a reasonable endeavours basis. Normally we would clarify this information before writing out to you, however given the very short response deadline set by the company that is not feasible in this instance.

sharw
20/5/2021
09:56
Nothing on the Tellus IPO yet from A J Bell (I've alerted them.)
Has anyone had notification from their platform provider?
CD

cambridgedon
20/5/2021
08:17
Those who attended the AGM meeting will have noted why JB, in answer to a question, indicated why, on several important fronts, that the private sector partner is not ultimately regarded as a threat.

So, with that in mind it's worth considering the following excerpt from the AGM Statement -

One of the great strengths of our business has been the establishment of an enviable distribution network in Point-of-care and we believe we are well positioned to maximise the value of this network, both for existing and new EKF product deployments as well as after providing development services for white labelled third-party products, leveraging already strong customer relationships.
(End)

With the above in mind, the following makes for an interesting read, in terms of what a strong relationship with private sector partner could achieve -

What Amazon's potential move into at-home medical tests could mean for the market
by Heather Landi | May 19, 2021

Taking a look at Amazon's investments over the last few years, including its acquisition of PillPack and launch of Amazon Pharmacy, the focus on employer health, investments in home diagnostics due to the pandemic, and the announcement and expansion of Amazon Care, home testing and diagnostic lab services seems a likely area for Amazon to expand its healthcare ambitions, analysts say.

"Labs are a particularly good fit for the core strengths of Amazon. Distribution and supply chain, scale and cost advantage, and digital customer and patient engagement all pointed at reducing friction and likely ultimately improving use and access frequency," Nathan Ray, a director in the healthcare and life sciences practice at business and technology consulting firm West Monroe, told Fierce Healthcare.

Amazon also made a major move into the health wearables market with the launch of the Amazon Halo fitness tracker last year.

There is the potential for the tech giant to create synergies with its different healthcare plays, Michael Abrams, a managing partner at consulting firm Numerof & Associates, told Fierce Healthcare.

"The Halo device can monitor the vitals of someone with a chronic disease, Alexa can then remind them that it's time to make an appointment they can do a virtual visit and also get a test kit in the mail for lab testing. It's all very synergistic," he said.

Abrams added, "They are taking steps that are synergistic. Amazon Care is synergistic with Amazon Pharmacy and both of them would be synergistic with a diagnostics line of business as well."

A potential expansion into health diagnostics would represent the next phase of growth for Amazon's in-house COVID-19 testing lab as the threat of the COVID-19 pandemic diminishes. Business Insider reported that the company previously said it had spent "hundreds of millions of dollars" in building the lab.

"When Amazon puts a lot of money into something that has potential in the healthcare marketplace, they try it out with their employees and, if it works well, they take it public," Abrams said, noting the expansion of Amazon Care to other companies as an employee benefit.

Beyond COVID-19 testing, Amazon's potential move into diagnostics is most interesting in the broader employer space, Ray said.

"There is the potential to help employers receive better population-level information on their entire workforce including those that do not frequently engage with the health system. It could also be an interesting marketplace for new diagnostic test providers and even for your own physician to more easily and regularly order testing," he said.

This week, Amazon rolled out a new employee wellness program called WorkingWell, aimed at preventing injuries, providing wellness services, and offering quality healthcare for employees while at work and at home. By the end of 2021, WorkingWell will expand further to cover all of Amazon’s operations network in the U.S. with the aim of cutting recordable incident rates by 50 percent by 2025, the company announced in a press release.

A move into home diagnostics would put Amazon in direct competition with testing giants LabCorp and Quest as well as other at-home testing kit startups. Retailers such as Kroger, Walmart and Albertsons launched their own home-testing services for general consumers over the past year, Business Insider reported.

"I think we're on the verge of an explosion in at-home diagnostics, considering the new technologies out there," said Abrams.

He speculated that if Amazon jumped into the diagnostics space the company would take the same merchandising approach as with its other products by offering third-party lines and launching its own line of diagnostics.

"Existing players in the space might have to sell through Amazon’s platform and hoping that they don’t choose to come out with their own brand of at-home diagnostics. That’s a tough fight to win as it will drive margins down," he said.

Full story -

To my mind, EKF's development services for white labelled third-party products should sit very well in providing for certain private sector partners ambitions for own brand of at-home diagnostics.

wan
20/5/2021
07:26
Worthy of note today -

SourceBio International PLC National Framework contract
20/05/2021

SourceBio International accepted for UK-wide National Microbiology Framework (Lot 4) tender

and

Further COVID-19 Government testing approvals for Day 2 and Day 8 testing

Full release -

wan
19/5/2021
22:06
How much are the Trellus shares going for, or is that about to be announced?
adobbing
19/5/2021
21:44
Draft Admission document here:
mirandaj
19/5/2021
21:09
ppmm, I didn't manage to dial in but have met Julian Baines many times and he's always been forthright and open - even after Stanbio acquisition and in a somewhat painful period for the company. So agree with your sentiments.

And I emailed the Trellus CFO and he emailed back (pretty quickly) confirming it is planned for tomorrow, so hopefully my ISA provider will be on the ball so I can participate in the restricted offer.

cisk
19/5/2021
20:49
I listened to the AGM today and have listened to a few of the companies i’m invested in or considering recently. The kind of detail regarding the business and future plans that EKF have willingly given I think is a shareholder is invaluable and resulted in the removal of any doubts during the recent selloff and helps plan my portfolio into the future.
ppmm
19/5/2021
20:41
Cisk, it says that information will be made available once the pricing and the raising of funds has been confirmed. That’s expected on 19th or shortly after. No information yet so may be tomorrow.
ppmm
19/5/2021
16:51
thanks ppmm, I'm out of the country at the moment so cannot access the investor section of trellus website... I've emailed them but not hopeful for a timely reply
cisk
19/5/2021
16:23
EKF are to be commended on their AGM statement today in terms of its clarity over a number of key areas - many others in the sector could learn from this.
nxc
Chat Pages: Latest  146  145  144  143  142  141  140  139  138  137  136  135  Older

Your Recent History

Delayed Upgrade Clock